SBS:ETR
Stratec SE
23,55 €
arrow_upward
+0,43%(+0,100) 1D
13-окт., 09:33:06 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SBS...
Open
23,30 €
High
23,80 €
Low
23,30 €
Mkt. cap
286,98 млн
Avg. vol.
13,70 миң
Volume
1,53 миң
Dividend
2,55%
Quarterly dividend
0,15 €
Ex-dividend date
2026-ж., 24-июн.
52-wk high
29,50 €
52-wk low
16,30 €
EPS
-0,03 €
Shares outstanding
12,16 млн
No. of employees
1 миң
Open
23,30 €
High
23,80 €
Low
23,30 €
Mkt. cap
286,98 млн
Avg. vol.
13,70 миң
Volume
1,53 миң
Dividend
2,55%
Quarterly dividend
0,15 €
Ex-dividend date
2026-ж., 24-июн.
52-wk high
29,50 €
52-wk low
16,30 €
EPS
-0,03 €
Shares outstanding
12,16 млн
No. of employees
1 миң
News stories
From web sources and news partners
ad-hoc-news.de
·
6 саат мурун
mwb research downgraded Stratec stock to Sell at EUR 21.00 target
Profile
STRATEC SE is a company with worldwide operations that designs and manufactures fully automated analyzer systems for partners in clinical diagnostics and biotechnology - particularly in the field of in-vitro-diagnostics.
As a classic original equipment manufacturer supplier, STRATEC produces its systems almost exclusively on behalf of its customers. Alongside the systems themselves, the company also provides sample preparation solutions, system software and integrated laboratory software. STRATEC is also responsible for development documentation, testing, delivery of systems, and the supply of spare parts and complex consumables for diagnostic and medical applications. STRATEC's customers are well known diagnostic companies like DiaSorin, Abbott, SIEMENS, Bio-Rad or Hologic. Wikipedia
About Stratec SE